jcp conference-coverage

Conference Coverage

Cost-Effectiveness of Perioperative Chemotherapy vs Adjuvant Chemoradiotherapy for Gastric Cancer

07/07/2021

A recent study comparing perioperative chemotherapy and adjuvant chemoradiotherapy for the treatment of gastric cancer identified the more cost-effective treatment of the two.

A recent study comparing...

07/07/2021

Journal of Clinical Pathways

Conference Coverage

Real-world Treatment Patterns and Outcomes Among Patients With MCL in the United States

07/02/2021

Findings from a real-world study show bendamustine plus rituximab was the most commonly used first-line treatment for MCL in the United States and that receipt of stem cell transplant was not common.

Findings from a real-world study...

07/02/2021

Journal of Clinical Pathways

Conference Coverage

Health Care Burden of Patients Hospitalized for Testicular Carcinoma

07/02/2021

Increasing costs of stay for patients hospitalized with testicular carcinoma are out of proportion with increases in length of stay, leading to significant financial toxicity for these patients.

Increasing costs of stay for...

07/02/2021

Journal of Clinical Pathways

Conference Coverage

Real-world PSA Progression After Enzalutamide or Abiraterone for Metastatic CRPC

06/24/2021

A real-world study presented at the virtual 2021 ASCO Annual Meeting evaluated prostate-specific antigen pattern progression and its association with OS among patients with metastatic CRPC who were treated with enzalutamide or abiraterone.

A real-world study presented at...

06/24/2021

Journal of Clinical Pathways

Conference Coverage

Cost-Effectiveness of Two Testing Strategies for BRCA Mutations in Ovarian Cancer

06/23/2021

A study presented at the virtual 2021 ASCO Annual Meeting compared the cost-effectiveness of two testing strategies for patients with ovarian cancer.

A study presented at the virtual...

06/23/2021

Journal of Clinical Pathways

Conference Coverage

Real-World Patterns and Predictors of First-Line Maintenance Therapy Use in Ovarian Cancer

06/23/2021

First-line maintenance therapy use for ovarian cancer has increased over time, particularly among patients with biomarker guidance.

First-line maintenance therapy...

06/23/2021

Journal of Clinical Pathways

Conference Coverage

Physician- and Patient-Reported Outcomes Among Five Radiotherapy Methods for Prostate Cancer

06/21/2021

A recent study comparing radiotherapy methods for prostate cancer suggests that physician-reported toxicities may be lower for patients treated with high-dose-rate brachytherapy, and patient-reported outcomes may be worse for those treated...

A recent study comparing...

06/21/2021

Journal of Clinical Pathways

Conference Coverage

Clinical and Economic Burden of First-Line Chemoimmunotherapy for CLL/SLL

06/21/2021

Between high-risk and nonhigh-risk patients with CLL or SLL initiating first-line chemoimmunotherapy, high-risk patients experience greater risk of next treatment or death, treatment failure, and higher costs.

Between high-risk and...

06/21/2021

Journal of Clinical Pathways

Conference Coverage

Real-World First-Line Treatment Patterns in Commercially Insured Patients With CSPC

06/17/2021

A majority of commercially insured and Medicare patients with metastatic castration-sensitive prostate cancer may not be receiving optimal life-prolonging therapies.

A majority of commercially...

06/17/2021

Journal of Clinical Pathways

Conference Coverage

An International Analysis of Treatments and Outcomes Among Patients with Epithelial Ovarian Cancer

06/17/2021

A new study suggests variation in patient populations between sites, and differences in treatments and outcomes across international networks of epithelial ovarian cancer treatment centers.

A new study suggests variation...

06/17/2021

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products